RISANKIZUMAB INDUCTION THERAPY PROVIDES EARLY SYMPTOM IMPROVEMENTS IN ABDOMINAL PAIN AND STOOL FREQUENCY IN PATIENTS WITH MODERATE TO SEVERE CROHN’S DISEASE: RESULTS FROM TWO PHASE 3 INDUCTION STUDIES

Joanne Rizzo  1     Jean-Frédéric Colombel  2     Stefan Schreiber  3     Geert R. D'Haens  4     Jenny Griffith  1     Javier Zambrano  1     Qian Zhou  5     Remo Panaccione     Marla C. Dubinsky     Jasmina Kalabic     Florian Rieder     Kristina Kligys    
1 AbbVie Inc.,North Chicago,United States
2 Icahn School of Medicine at Mount Sinai,New York,United States
3 University Hospital Schleswig-Holstein, Kiel University,Kiel,Germany
4 Amsterdam University Medical Center,Amsterdam,Netherlands
5 AbbVie Inc.,North C

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing